Main variables;Fields of operation;Total
Units that perform R+D in Biotechnology;Total;1.328
Units that perform R+D in Biotechnology;Units;1.133
Units that perform R+D in Biotechnology;P.A.;123
Units that perform R+D in Biotechnology;Higher Education;64
Units that perform R+D in Biotechnology;PNPI;8
%Units according to biotechnology used: Genetic code;Total;40
%Units according to biotechnology used: Genetic code;Units;32
%Units according to biotechnology used: Genetic code;P.A.;90
%Units according to biotechnology used: Genetic code;Higher Education;89
%Units according to biotechnology used: Genetic code;PNPI;63
%Units according to biotechnology used: Functional units;Total;48
%Units according to biotechnology used: Functional units;Units;41
%Units according to biotechnology used: Functional units;P.A.;87
%Units according to biotechnology used: Functional units;Higher Education;95
%Units according to biotechnology used: Functional units;PNPI;25
%Units according to biotechnology used: Cellular and tissue culturing and engineering;Total;34
%Units according to biotechnology used: Cellular and tissue culturing and engineering;Units;27
%Units according to biotechnology used: Cellular and tissue culturing and engineering;P.A.;74
%Units according to biotechnology used: Cellular and tissue culturing and engineering;Higher Education;84
%Units according to biotechnology used: Cellular and tissue culturing and engineering;PNPI;63
%Units according to biotechnology used: Bioprocesses;Total;51
%Units according to biotechnology used: Bioprocesses;Units;48
%Units according to biotechnology used: Bioprocesses;P.A.;56
%Units according to biotechnology used: Bioprocesses;Higher Education;92
%Units according to biotechnology used: Bioprocesses;PNPI;50
%Units according to biotechnology used: Sub-cellular organisms;Total;16
%Units according to biotechnology used: Sub-cellular organisms;Units;8
%Units according to biotechnology used: Sub-cellular organisms;P.A.;53
%Units according to biotechnology used: Sub-cellular organisms;Higher Education;72
%Units according to biotechnology used: Sub-cellular organisms;PNPI;25
%Units according to biotechnology used: Bio-computing;Total;29
%Units according to biotechnology used: Bio-computing;Units;21
%Units according to biotechnology used: Bio-computing;P.A.;70
%Units according to biotechnology used: Bio-computing;Higher Education;86
%Units according to biotechnology used: Bio-computing;PNPI;25
%Units according to biotechnology used: Nanobiotechnology;Total;20
%Units according to biotechnology used: Nanobiotechnology;Units;14
%Units according to biotechnology used: Nanobiotechnology;P.A.;45
%Units according to biotechnology used: Nanobiotechnology;Higher Education;73
%Units according to biotechnology used: Nanobiotechnology;PNPI;13
%Units according to biotechnology used: Other;Total;13
%Units according to biotechnology used: Other;Units;13
%Units according to biotechnology used: Other;P.A.;11
%Units according to biotechnology used: Other;Higher Education;13
%Units according to biotechnology used: Other;PNPI;13
Units in which biotechnology activities are:  Main and/or exclusive;Total;608
Units in which biotechnology activities are:  Main and/or exclusive;Units;564
Units in which biotechnology activities are:  Main and/or exclusive;P.A.;36
Units in which biotechnology activities are:  Main and/or exclusive;Higher Education;3
Units in which biotechnology activities are:  Main and/or exclusive;PNPI;5
Units in which biotechnology activities are: A secondary line of business;Total;294
Units in which biotechnology activities are: A secondary line of business;Units;212
Units in which biotechnology activities are: A secondary line of business;P.A.;37
Units in which biotechnology activities are: A secondary line of business;Higher Education;43
Units in which biotechnology activities are: A secondary line of business;PNPI;2
Units in which biotechnology activities are: A tool necessary for production;Total;427
Units in which biotechnology activities are: A tool necessary for production;Units;358
Units in which biotechnology activities are: A tool necessary for production;P.A.;50
Units in which biotechnology activities are: A tool necessary for production;Higher Education;18
Units in which biotechnology activities are: A tool necessary for production;PNPI;1
%Units by field(s) of ultimate application of biotechnology use: Human health;Total;55
%Units by field(s) of ultimate application of biotechnology use: Human health;Units;50
%Units by field(s) of ultimate application of biotechnology use: Human health;P.A.;77
%Units by field(s) of ultimate application of biotechnology use: Human health;Higher Education;92
%Units by field(s) of ultimate application of biotechnology use: Human health;PNPI;75
%Units by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture;Total;21
%Units by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture;Units;19
%Units by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture;P.A.;19
%Units by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture;Higher Education;59
%Units by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture;PNPI;13
%Units by field(s) of ultimate application of biotechnology use: Food products;Total;31
%Units by field(s) of ultimate application of biotechnology use: Food products;Units;29
%Units by field(s) of ultimate application of biotechnology use: Food products;P.A.;20
%Units by field(s) of ultimate application of biotechnology use: Food products;Higher Education;86
%Units by field(s) of ultimate application of biotechnology use: Food products;PNPI;13
%Units by field(s) of ultimate application of biotechnology use: Agriculture and forest production:;Total;24
%Units by field(s) of ultimate application of biotechnology use: Agriculture and forest production:;Units;21
%Units by field(s) of ultimate application of biotechnology use: Agriculture and forest production:;P.A.;20
%Units by field(s) of ultimate application of biotechnology use: Agriculture and forest production:;Higher Education;72
%Units by field(s) of ultimate application of biotechnology use: Agriculture and forest production:;PNPI;25
%Units by field(s) of ultimate application of biotechnology use: Environment;Total;17
%Units by field(s) of ultimate application of biotechnology use: Environment;Units;13
%Units by field(s) of ultimate application of biotechnology use: Environment;P.A.;23
%Units by field(s) of ultimate application of biotechnology use: Environment;Higher Education;73
%Units by field(s) of ultimate application of biotechnology use: Environment;PNPI;25
%Units by field(s) of ultimate application of biotechnology use: Industry;Total;16
%Units by field(s) of ultimate application of biotechnology use: Industry;Units;13
%Units by field(s) of ultimate application of biotechnology use: Industry;P.A.;12
%Units by field(s) of ultimate application of biotechnology use: Industry;Higher Education;70
%Units by field(s) of ultimate application of biotechnology use: Industry;PNPI;25
Personnel in R&D in biotechnology (no. of persons);Total;35.705
Personnel in R&D in biotechnology (no. of persons);Units;10.706
Personnel in R&D in biotechnology (no. of persons);P.A.;12.279
Personnel in R&D in biotechnology (no. of persons);Higher Education;12.405
Personnel in R&D in biotechnology (no. of persons);PNPI;315
Personnel in R&D in biotechnology (no. of persons): Researchers;Total;23.534
Personnel in R&D in biotechnology (no. of persons): Researchers;Units;6.227
Personnel in R&D in biotechnology (no. of persons): Researchers;P.A.;7.396
Personnel in R&D in biotechnology (no. of persons): Researchers;Higher Education;9.662
Personnel in R&D in biotechnology (no. of persons): Researchers;PNPI;249
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants;Total;12.171
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants;Units;4.479
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants;P.A.;4.883
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants;Higher Education;2.743
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants;PNPI;66
Personnel in R&D in biotechnology (no. of persons): women;Total;19.535
Personnel in R&D in biotechnology (no. of persons): women;Units;5.795
Personnel in R&D in biotechnology (no. of persons): women;P.A.;7.333
Personnel in R&D in biotechnology (no. of persons): women;Higher Education;6.213
Personnel in R&D in biotechnology (no. of persons): women;PNPI;194
Personnel in R&D in biotechnology (no. of persons): (women) Researchers;Total;12.149
Personnel in R&D in biotechnology (no. of persons): (women) Researchers;Units;3.269
Personnel in R&D in biotechnology (no. of persons): (women) Researchers;P.A.;4.137
Personnel in R&D in biotechnology (no. of persons): (women) Researchers;Higher Education;4.591
Personnel in R&D in biotechnology (no. of persons): (women) Researchers;PNPI;152
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants;Total;7.387
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants;Units;2.527
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants;P.A.;3.196
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants;Higher Education;1.622
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants;PNPI;42
Personnel in R&D in biotechnology (FTE);Total;24.830,2
Personnel in R&D in biotechnology (FTE);Units;7.716,4
Personnel in R&D in biotechnology (FTE);P.A.;9.470,2
Personnel in R&D in biotechnology (FTE);Higher Education;7.544,3
Personnel in R&D in biotechnology (FTE);PNPI;99,3
Personnel in R&D in biotechnology (FTE): Researchers;Total;15.765,2
Personnel in R&D in biotechnology (FTE): Researchers;Units;4.603,1
Personnel in R&D in biotechnology (FTE): Researchers;P.A.;5.358,9
Personnel in R&D in biotechnology (FTE): Researchers;Higher Education;5.744,2
Personnel in R&D in biotechnology (FTE): Researchers;PNPI;59
Personnel in R&D in biotechnology (FTE): Technicians and assistants;Total;9.065
Personnel in R&D in biotechnology (FTE): Technicians and assistants;Units;3.113,3
Personnel in R&D in biotechnology (FTE): Technicians and assistants;P.A.;4.111,3
Personnel in R&D in biotechnology (FTE): Technicians and assistants;Higher Education;1.800,1
Personnel in R&D in biotechnology (FTE): Technicians and assistants;PNPI;40,3
Personnel in R&D in biotechnology (FTE): women;Total;14.026,5
Personnel in R&D in biotechnology (FTE): women;Units;4.292,9
Personnel in R&D in biotechnology (FTE): women;P.A.;5.768,1
Personnel in R&D in biotechnology (FTE): women;Higher Education;3.898,4
Personnel in R&D in biotechnology (FTE): women;PNPI;67,1
Personnel in R&D in biotechnology (FTE): (women) Researchers;Total;8.366,6
Personnel in R&D in biotechnology (FTE): (women) Researchers;Units;2.446,4
Personnel in R&D in biotechnology (FTE): (women) Researchers;P.A.;3.075,3
Personnel in R&D in biotechnology (FTE): (women) Researchers;Higher Education;2.804,9
Personnel in R&D in biotechnology (FTE): (women) Researchers;PNPI;40
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants;Total;5.659,9
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants;Units;1.846,5
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants;P.A.;2.692,8
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants;Higher Education;1.093,5
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants;PNPI;27,1
Internal expenditure on R&D (thousands of euros);Total;1.579.928
Internal expenditure on R&D (thousands of euros);Units;616.053
Internal expenditure on R&D (thousands of euros);P.A.;578.188
Internal expenditure on R&D (thousands of euros);Higher Education;380.311
Internal expenditure on R&D (thousands of euros);PNPI;5.376
1) By nature of the expense: Current expenses;Total;1.488.894
1) By nature of the expense: Current expenses;Units;574.245
1) By nature of the expense: Current expenses;P.A.;551.435
1) By nature of the expense: Current expenses;Higher Education;358.168
1) By nature of the expense: Current expenses;PNPI;5.046
1.1) Remuneration to researchers;Total;639.606
1.1) Remuneration to researchers;Units;221.741
1.1) Remuneration to researchers;P.A.;207.123
1.1) Remuneration to researchers;Higher Education;208.812
1.1) Remuneration to researchers;PNPI;1.930
1.2) Remuneration to technicians and assistants;Total;273.257
1.2) Remuneration to technicians and assistants;Units;102.464
1.2) Remuneration to technicians and assistants;P.A.;114.013
1.2) Remuneration to technicians and assistants;Higher Education;56.002
1.2) Remuneration to technicians and assistants;PNPI;779
1.3) Other current expenses;Total;576.031
1.3) Other current expenses;Units;250.041
1.3) Other current expenses;P.A.;230.300
1.3) Other current expenses;Higher Education;93.354
1.3) Other current expenses;PNPI;2.337
2) By nature of the expense: Capital expenses;Total;91.034
2) By nature of the expense: Capital expenses;Units;41.808
2) By nature of the expense: Capital expenses;P.A.;26.752
2) By nature of the expense: Capital expenses;Higher Education;22.144
2) By nature of the expense: Capital expenses;PNPI;330
2.1) Land and buildings;Total;15.476
2.1) Land and buildings;Units;5.359
2.1) Land and buildings;P.A.;4.304
2.1) Land and buildings;Higher Education;5.813
2.1) Land and buildings;PNPI;.
2.2) Equipment and instruments;Total;66.410
2.2) Equipment and instruments;Units;29.489
2.2) Equipment and instruments;P.A.;21.427
2.2) Equipment and instruments;Higher Education;15.163
2.2) Equipment and instruments;PNPI;330
2.3) Acquisition of specific R+D software;Total;4.363
2.3) Acquisition of specific R+D software;Units;2.306
2.3) Acquisition of specific R+D software;P.A.;956
2.3) Acquisition of specific R+D software;Higher Education;1.102
2.3) Acquisition of specific R+D software;PNPI;.
2.4) Otros productos de propiedad intelectual específicos para I+D;Total;4.785
2.4) Otros productos de propiedad intelectual específicos para I+D;Units;4.654
2.4) Otros productos de propiedad intelectual específicos para I+D;P.A.;65
2.4) Otros productos de propiedad intelectual específicos para I+D;Higher Education;66
2.4) Otros productos de propiedad intelectual específicos para I+D;PNPI;.
1) By origin of the funds: National funds;Total;1.383.507
1) By origin of the funds: National funds;Units;511.960
1) By origin of the funds: National funds;P.A.;533.002
1) By origin of the funds: National funds;Higher Education;333.525
1) By origin of the funds: National funds;PNPI;5.020
1.1) Own funds;Total;510.526
1.1) Own funds;Units;382.335
1.1) Own funds;P.A.;66.621
1.1) Own funds;Higher Education;60.810
1.1) Own funds;PNPI;761
1.2) From companies;Total;119.013
1.2) From companies;Units;45.024
1.2) From companies;P.A.;42.520
1.2) From companies;Higher Education;29.798
1.2) From companies;PNPI;1.672
1.3) Public Administration funds;Total;702.795
1.3) Public Administration funds;Units;72.387
1.3) Public Administration funds;P.A.;393.166
1.3) Public Administration funds;Higher Education;236.358
1.3) Public Administration funds;PNPI;884
1.4) From Universities;Total;2.790
1.4) From Universities;Units;363
1.4) From Universities;P.A.;2.018
1.4) From Universities;Higher Education;308
1.4) From Universities;PNPI;100
1.5) From non profit private institutions;Total;48.382
1.5) From non profit private institutions;Units;11.851
1.5) From non profit private institutions;P.A.;28.676
1.5) From non profit private institutions;Higher Education;6.251
1.5) From non profit private institutions;PNPI;1.603
1) By origin of the funds: Foreign funds;Total;196.421
1) By origin of the funds: Foreign funds;Units;104.093
1) By origin of the funds: Foreign funds;P.A.;45.186
1) By origin of the funds: Foreign funds;Higher Education;46.786
1) By origin of the funds: Foreign funds;PNPI;356
2.1) From EU programmes;Total;101.384
2.1) From EU programmes;Units;21.825
2.1) From EU programmes;P.A.;39.684
2.1) From EU programmes;Higher Education;39.875
2.1) From EU programmes;PNPI;.
2.2) Other foreign funds;Total;95.037
2.2) Other foreign funds;Units;82.269
2.2) Other foreign funds;P.A.;5.501
2.2) Other foreign funds;Higher Education;6.911
2.2) Other foreign funds;PNPI;356
Purchase of services R & D in Biotechnology to (thousands of euros);Total;167.608
Purchase of services R & D in Biotechnology to (thousands of euros);Units;144.342
Purchase of services R & D in Biotechnology to (thousands of euros);P.A.;20.609
Purchase of services R & D in Biotechnology to (thousands of euros);Higher Education;2.618
Purchase of services R & D in Biotechnology to (thousands of euros);PNPI;38
Purchase of services R & D in Biotechnology to (thousands of euros): in Spain;Total;92.199
Purchase of services R & D in Biotechnology to (thousands of euros): in Spain;Units;70.458
Purchase of services R & D in Biotechnology to (thousands of euros): in Spain;P.A.;19.167
Purchase of services R & D in Biotechnology to (thousands of euros): in Spain;Higher Education;2.536
Purchase of services R & D in Biotechnology to (thousands of euros): in Spain;PNPI;38
Purchase of services R & D in Biotechnology to (thousands of euros): Abroad;Total;75.409
Purchase of services R & D in Biotechnology to (thousands of euros): Abroad;Units;73.885
Purchase of services R & D in Biotechnology to (thousands of euros): Abroad;P.A.;1.442
Purchase of services R & D in Biotechnology to (thousands of euros): Abroad;Higher Education;82
Purchase of services R & D in Biotechnology to (thousands of euros): Abroad;PNPI;.
%Units that consider the following obstacles as very important considering biotechnology development: Access to capital;Total;49
%Units that consider the following obstacles as very important considering biotechnology development: Access to capital;Units;48
%Units that consider the following obstacles as very important considering biotechnology development: Access to capital;P.A.;56
%Units that consider the following obstacles as very important considering biotechnology development: Access to capital;Higher Education;53
%Units that consider the following obstacles as very important considering biotechnology development: Access to capital;PNPI;75
%Units that consider the following obstacles as very important considering biotechnology development: Access to technology / information;Total;12
%Units that consider the following obstacles as very important considering biotechnology development: Access to technology / information;Units;13
%Units that consider the following obstacles as very important considering biotechnology development: Access to technology / information;P.A.;7
%Units that consider the following obstacles as very important considering biotechnology development: Access to technology / information;Higher Education;9
%Units that consider the following obstacles as very important considering biotechnology development: Access to technology / information;PNPI;0
%Units that consider the following obstacles as very important considering biotechnology development: Access to human resources;Total;18
%Units that consider the following obstacles as very important considering biotechnology development: Access to human resources;Units;15
%Units that consider the following obstacles as very important considering biotechnology development: Access to human resources;P.A.;39
%Units that consider the following obstacles as very important considering biotechnology development: Access to human resources;Higher Education;36
%Units that consider the following obstacles as very important considering biotechnology development: Access to human resources;PNPI;25
%Units that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain;Total;15
%Units that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain;Units;12
%Units that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain;P.A.;26
%Units that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain;Higher Education;27
%Units that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain;PNPI;38
%Units that consider the following obstacles as very important considering biotechnology development: Lack of access to international markets;Total;18
%Units that consider the following obstacles as very important considering biotechnology development: Lack of access to international markets;Units;16
%Units that consider the following obstacles as very important considering biotechnology development: Lack of access to international markets;P.A.;31
%Units that consider the following obstacles as very important considering biotechnology development: Lack of access to international markets;Higher Education;41
%Units that consider the following obstacles as very important considering biotechnology development: Lack of access to international markets;PNPI;25
%Units that consider the following obstacles as very important considering biotechnology development: Lack of distribution and marketing channels;Total;19
%Units that consider the following obstacles as very important considering biotechnology development: Lack of distribution and marketing channels;Units;16
%Units that consider the following obstacles as very important considering biotechnology development: Lack of distribution and marketing channels;P.A.;34
%Units that consider the following obstacles as very important considering biotechnology development: Lack of distribution and marketing channels;Higher Education;36
%Units that consider the following obstacles as very important considering biotechnology development: Lack of distribution and marketing channels;PNPI;38
%Units that consider the following obstacles as very important considering biotechnology development: Acceptance / public perception;Total;15
%Units that consider the following obstacles as very important considering biotechnology development: Acceptance / public perception;Units;16
%Units that consider the following obstacles as very important considering biotechnology development: Acceptance / public perception;P.A.;12
%Units that consider the following obstacles as very important considering biotechnology development: Acceptance / public perception;Higher Education;14
%Units that consider the following obstacles as very important considering biotechnology development: Acceptance / public perception;PNPI;38
%Units that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements;Total;36
%Units that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements;Units;36
%Units that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements;P.A.;35
%Units that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements;Higher Education;27
%Units that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements;PNPI;50
%Units that consider the following obstacles as very important considering biotechnology development: Time / cost;Total;49
%Units that consider the following obstacles as very important considering biotechnology development: Time / cost;Units;49
%Units that consider the following obstacles as very important considering biotechnology development: Time / cost;P.A.;50
%Units that consider the following obstacles as very important considering biotechnology development: Time / cost;Higher Education;55
%Units that consider the following obstacles as very important considering biotechnology development: Time / cost;PNPI;50
%Units that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting;Total;18
%Units that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting;Units;18
%Units that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting;P.A.;20
%Units that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting;Higher Education;14
%Units that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting;PNPI;38
%Units that have requested biotechnology patents in Biotechnology;Total;21
%Units that have requested biotechnology patents in Biotechnology;Units;16
%Units that have requested biotechnology patents in Biotechnology;P.A.;45
%Units that have requested biotechnology patents in Biotechnology;Higher Education;73
%Units that have requested biotechnology patents in Biotechnology;PNPI;.
Number of patents requested;Total;1.809
Number of patents requested;Units;633
Number of patents requested;P.A.;690
Number of patents requested;Higher Education;486
Number of patents requested;PNPI;.